Vice President, Innovative Product Portfolio Management, Pfizer Global Supply
Kirsten Lund-Jurgensen has been with Pfizer since 1999, holding Vice Presidential roles in Global Supply Chain Management, Manufacturing Operations, and Product and Portfolio Management. She has been a member of the Pfizer Global Supply (PGS) Executive Team since 2000. As a PGS Leader, she has been a member of several commercial leadership teams including Consumer Healthcare, Specialty Care, Primary Care, Established Products, Vaccines, Oncology and Consumer (VOC), Global Innovative Pharma (GIP), and now Innovative Health (IH).
Prior to Pfizer, Kirsten Lund-Jurgensen worked for SmithKline Beecham from 1987-1999. Several plant operational and functional roles in Germany and Australia ultimately prepared her for her roles as VP European Contractor Management and VP of Global Strategic Planning in the US.
Ms. Lund-Jurgensen has chaired Pfizers Environmental Sustainability Council since 2009 and was elected to the Pfizer Foundation Board in 2008.
A pharmacist by training, she holds a Ph.D. in Pharmaceutical Biology from Freiburg University in Germany.
Executive Forum: Sustainability as a Value Creator and Growth Generator
“Sustainability is now a business imperative to ensure the long-term growth of manufacturing operations and the vitality of the communities in which they operate," said Christophe Beck, Ecolab executive vice president and president, Nalco Water, and a keynote speaker at the NAM's Leading Edge Executive Forum held in Chicago on October 13.